» Articles » PMID: 23183822

Epigenetic Regulation of MiRNA-211 by MMP-9 Governs Glioma Cell Apoptosis, Chemosensitivity and Radiosensitivity

Overview
Journal Oncotarget
Specialty Oncology
Date 2012 Nov 28
PMID 23183822
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma multiforme (GBM) is the most aggressive brain cancer, and to date, no curative treatment has been developed. In this study, we report that miR-211, a microRNA predicted to target MMP-9, is suppressed in grade IV GBM specimens. Furthermore, we found that miR-211 suppression in GBM involves aberrant methylation-mediated epigenetic silencing of the miR-211 promoter. Indeed, we observed a highly significant inverse correlation between miR-211 expression and MMP-9 protein levels, which is indicative of post-transcriptional control of gene expression. Additionally, shRNA specific for MMP-9 (pM) promoted miR-211 expression via demethylation of miR-211 promoter-associated CpG islands (-140 to +56). In independent experiments, we confirmed that miR-211 overexpression and pM treatments led to the activation of the intrinsic mitochondrial/Caspase-9/3-mediated apoptotic pathway in both glioma cells and cancer stem cells (CSC). We also investigated whether miR-211 is involved in the regulation of MMP-9 and thus plays a functional role in GBM. We found an acute inhibitory effect of miR-211 on glioma cell invasion and migration via suppression of MMP-9. Given the insensitivity of some GBMs to radiation and chemotherapy (temozolomide) along with the hypothesis that glioma CSC cause resistance to therapy, our study indicates that miR-211 or pM in combination with ionizing radiation (IR) and temozolomide significantly induces apoptosis and DNA fragmentation. Of note, miR-211- and pM-treated CSC demonstrated increased drug retention capacity, as observed by MDR1/P-gp mediated-Rhodamine 123 drug efflux activity assay. These results suggest that either rescuing miR-211 expression or downregulation of MMP-9 may have a new therapeutic application for GBM patients in the future.

Citing Articles

Temozolomide promotes matrix metalloproteinase 9 expression through p38 MAPK and JNK pathways in glioblastoma cells.

Thanh H, Lee S, Nguyen T, Huu T, Ahn E, Cho S Sci Rep. 2024; 14(1):14341.

PMID: 38906916 PMC: 11192740. DOI: 10.1038/s41598-024-65398-2.


Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).

Li K, Li D, Hafez B, Bekhit M, Bin Jardan Y, Alanazi F Oncol Res. 2024; 32(4):737-752.

PMID: 38560573 PMC: 10972725. DOI: 10.32604/or.2023.042925.


Expression profiles of MMP-9 and EMMPRIN in chronic rhinosinusitis with nasal polyps.

Lygeros S, Danielides G, Kyriakopoulos G, Tsapardoni F, Grafanaki K, Stathopoulos C Acta Otorhinolaryngol Ital. 2023; 43(6):400-408.

PMID: 37519135 PMC: 10773546. DOI: 10.14639/0392-100X-N2197.


Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization.

Silver A, Feier D, Ghosh T, Rahman M, Huang J, Sarkisian M Front Oncol. 2022; 12:1022716.

PMID: 36338705 PMC: 9628999. DOI: 10.3389/fonc.2022.1022716.


Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play.

Chulia-Peris L, Carreres-Rey C, Gabasa M, Alcaraz J, Carretero J, Pereda J Int J Mol Sci. 2022; 23(13).

PMID: 35805895 PMC: 9267107. DOI: 10.3390/ijms23136894.


References
1.
Jimenez R, Hartwig W, Antoniu B, Compton C, Warshaw A, Fernandez-Del Castillo C . Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. Ann Surg. 2000; 231(5):644-54. PMC: 1421051. DOI: 10.1097/00000658-200005000-00004. View

2.
Susskind H, Hymowitz M, Lau Y, Atkins H, Hurewitz A, Valentine E . Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy. Int J Radiat Oncol Biol Phys. 2003; 56(4):1161-9. DOI: 10.1016/s0360-3016(03)00161-5. View

3.
Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb J, Peck D . MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043):834-8. DOI: 10.1038/nature03702. View

4.
Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

5.
Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View